Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Inhibrx Biosciences (INBX) Other Non Operating Income: 2023-2025

Historic Other Non Operating Income for Inhibrx Biosciences (INBX) over the last 3 years, with Sep 2025 value amounting to -$46,000.

  • Inhibrx Biosciences' Other Non Operating Income fell 212.20% to -$46,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$282,000, marking a year-over-year decrease of 97.20%. This contributed to the annual value of $75,000 for FY2024, which is 112.93% up from last year.
  • Inhibrx Biosciences' Other Non Operating Income amounted to -$46,000 in Q3 2025, which was up 81.30% from -$246,000 recorded in Q2 2025.
  • In the past 5 years, Inhibrx Biosciences' Other Non Operating Income registered a high of $60,000 during Q4 2024, and its lowest value of -$246,000 during Q2 2025.
  • Its 3-year average for Other Non Operating Income is -$63,000, with a median of -$54,500 in 2024.
  • In the last 5 years, Inhibrx Biosciences' Other Non Operating Income surged by 147.14% in 2024 and then tumbled by 845.45% in 2025.
  • Inhibrx Biosciences' Other Non Operating Income (Quarterly) stood at -$158,000 in 2023, then skyrocketed by 137.97% to $60,000 in 2024, then plummeted by 212.20% to -$46,000 in 2025.
  • Its Other Non Operating Income was -$46,000 in Q3 2025, compared to -$246,000 in Q2 2025 and -$50,000 in Q1 2025.